SCHEMBL17658490

SCHEMBL17658490

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4c(c3)oc3c5ccc(-c6ccc(N(c7ccccc7)c7ccccc7)cc6)cc5c5ccccc5c43)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
HPGD P15428 3/20 0.32
TDP1 Q9NUW8 3/20 0.32
CASP7 P55210 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ALDH1A1 P00352 2/20 0.32
ESR1 P03372 2/20 0.32
TP53 P04637 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
BRCA1 P38398 1/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
HKDC1 Q2TB90 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RECQL P46063 3/20 0.32
BLM P54132 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17658510 1.00 PLA2G2A (0.34) PLA2G2APLA2G4AMEN1KMT2AHPGD
SCHEMBL17658415 0.99 MEN1 (0.32) PLA2G2APLA2G4AMEN1KMT2AHPGD
SCHEMBL17658485 0.96 MEN1 (0.32) MEN1KMT2AHPGDTDP1CASP7
SCHEMBL17658320 0.96 MEN1 (0.32) MEN1KMT2AHPGDTDP1CASP7
SCHEMBL17658482 0.96 PLA2G2A (0.35) PLA2G2APLA2G4AMEN1KMT2AHPGD
SCHEMBL17658483 0.96 MEN1 (0.32) MEN1KMT2AHPGDTDP1CASP7
SCHEMBL17658480 0.95 KDM4E (0.33) PLA2G2APLA2G4AMEN1KMT2AHPGD
SCHEMBL17658713 0.95 PLA2G2A (0.35) PLA2G2APLA2G4AMEN1KMT2AHPGD
SCHEMBL17658484 0.95 MEN1 (0.33) PLA2G2APLA2G4AMEN1KMT2AHPGD
SCHEMBL17658470 0.94 DYRK1A (0.33) MEN1KMT2AHPGDTDP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9856243-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-02 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, MCM4 PLA2G2A 4629/4885PLA2G4A 4587/4885MEN1 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.